Detailed definition
Obstructive sleep apnea (OSA) involves repeated upper-airway collapse during sleep, producing apneas (cessation of airflow ≥10 seconds) and hypopneas (significant airflow reduction with desaturation or arousal). The apnea-hypopnea index (AHI) classifies OSA as mild (5–15/hour), moderate (15–30/hour), or severe (>30/hour). OSA in women historically was underdiagnosed because clinical presentations differ from men: women more often present with insomnia, fatigue, depression, and headache rather than classic loud snoring. Postmenopausal prevalence rises significantly — from roughly 5% premenopausally to >20% in some postmenopausal cohorts — driven by loss of estrogen and progesterone's effects on upper-airway tone, fat redistribution, and respiratory drive. Diagnosis is by overnight sleep study (in-lab polysomnography or home sleep apnea test). Treatment is CPAP (continuous positive airway pressure), oral appliance therapy, positional therapy, weight management, or surgery, depending on severity and patient factors.
Why it matters in menopause
Untreated sleep apnea looks identical to severe menopausal fatigue, brain fog, and mood symptoms. A woman who has been on full HRT for 6 months and still feels exhausted should be screened for sleep apnea. CPAP can be life-changing for women misdiagnosed as treatment-resistant menopausal insomnia.
Related terms
Sources
External references: Wikipedia.